August 20, 2020, 4:00 pm — 4:45 pm
Due to the COVID-19 outbreak, Precision Medicine Thursdays at Venture Café have moved to Zoom.
Zoom Meeting Registration: https://zoom.us/meeting/register/tJIpd-mspj4qH9XEltnCyk0dcEI9-01zajeY
The Institute of Clinical and Translational Sciences (ICTS), in collaboration with Venture Café, is hosting Precision Medicine Series on the third Thursday of every month! This month at ICTS Precision Medicine Thursday, join us to hear two researchers from Washington University in St. Louis, Keith Hengen, PhD, Assistant Professor of Biology in the faculty of Arts & Sciences, and Shantanu Chakrabartty, PhD, Clifford W. Murphy Professor of Electrical & Systems Engineering in the McKelvey School of Engineering.
Neurological diseases, such as Alzheimer Disease, are widely blamed on the accumulation of toxic proteins. However, all attempts to intervene at the level of the protein have failed. Emerging tools and computational approaches are opening a door to considering diseases through the novel lens of complex systems – already, these methods are gathering significant explanatory power. We will discuss computation in large networks of neurons, and machine learning tools for decoding the underlying state of the brain. Additionally, we will discuss neuromorphic engineering and how some of these neuroscience insights could be translated into silicon chips.
Dr. Keith Hengen will talk about neuroscience and insights his groups have uncovered from measurements from neural recordings. Dr. Shantanu Chakrabartty will talk about neuromorphic engineering and how some of the neuroscience insights could be translated into silicon chips.
For more information, please contact Tricia Salyer, Precision Medicine Navigator at ICTS, at email@example.com.